Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test AFB Drug Susceptibility Test: Isoniazid is 21 days.

What are the prerequisites for the test AFB Drug Susceptibility Test: Isoniazid

  • Specimen: Pure culture of Mycobacterium tuberculosis
  • Media: Middlebrook 7H10 or 7H11 agar
  • Incubation: 37 degrees Celsius
  • Time: 21 days

What are the measure values for the test AFB Drug Susceptibility Test: Isoniazid

  • Minimum inhibitory concentration (MIC) breakpoint for susceptible: ≤0.1 µg/mL
  • Minimum inhibitory concentration (MIC) breakpoint for resistant: ≥0.2 µg/mL
  • Zone diameter breakpoint for susceptible: ≥18 mm
  • Zone diameter breakpoint for resistant: ≤15 mm

What does this test AFB Drug Susceptibility Test: Isoniazid identify?

This AFB Drug Susceptibility Test specifically identifies the susceptibility of the bacteria to the drug Isoniazid. Isoniazid is a first-line antibiotic used in the treatment of tuberculosis. This test helps determine whether the bacteria causing the infection are sensitive or resistant to Isoniazid. This information is crucial in guiding the appropriate treatment plan for the patient.

Why is this test AFB Drug Susceptibility Test: Isoniazid taken?

The AFB Drug Susceptibility Test: Isoniazid is taken to determine the effectiveness of the drug isoniazid in treating tuberculosis caused by mycobacterium tuberculosis. This test helps in identifying whether the bacteria are resistant or susceptible to isoniazid, which is a first-line drug for the treatment of tuberculosis. Knowing the susceptibility of the bacteria to isoniazid helps in determining the most appropriate treatment regimen for the patient, thereby improving the chances of successful treatment and reducing the risk of drug resistance.

No FAQs available.

Customer Google Rating